The electrical response of nerve to two stimuli.

PubWeight™: 1.27‹?› | Rank: Top 10%

🔗 View Article (PMC 1516649)

Published in J Physiol on July 28, 1899

Authors

F Gotch, G J Burch

Articles by these authors

The time relations of the photo-electric changes in the eyeball of the frog. J Physiol (1903) 31.79

The delay of the electrical response of nerve to a second stimulus. J Physiol (1910) 9.35

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med (1995) 5.22

Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature (1987) 4.66

Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes. J Exp Med (1987) 3.02

HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet (1993) 2.71

Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature (1990) 2.65

Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood (2001) 2.57

Temperature and Excitability. J Physiol (1896) 2.21

Cytotoxic lymphocytes from rats depleted of thymus processed cells. Nat New Biol (1971) 2.02

Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus. J Virol (2001) 1.92

The time-relations of the photo-electric changes produced in the eyeball of the frog by means of coloured light. J Physiol (1904) 1.88

Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protection. AIDS Res Hum Retroviruses (1998) 1.73

Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet (1995) 1.62

A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides. Eur J Immunol (1993) 1.48

Note on the so-called Tendon Reflex. J Physiol (1896) 1.46

The human cytotoxic T cell response to influenza A vaccination. Clin Exp Immunol (1981) 1.37

Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection. AIDS (1998) 1.35

Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes. Eur J Immunol (1992) 1.29

The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans (1992) 1.23

Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals. Clin Exp Immunol (2009) 1.20

On the Electrical Organ of the Skate. J Physiol (1888) 1.13

Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses. J Immunol (1995) 1.12

The submaximal electrical response of nerve to a single stimulus. J Physiol (1902) 1.09

HLA-C and guttate psoriasis. Br J Dermatol (2000) 1.08

A point mutation in CD45 may be associated with an increased risk of HIV-1 infection. AIDS (2001) 1.08

Identification of human herpesvirus 8-specific cytotoxic T-cell responses. J Virol (1999) 1.07

On D'Arsonval's Physical Theory of the Negative Variation. J Physiol (1894) 1.06

On the Electrical Organ of the Skate: Part II. J Physiol (1889) 1.06

Higher levels of activation markers and chemokine receptors on T lymphocytes in the cervix than peripheral blood of normal healthy women. J Reprod Immunol (2001) 0.96

Immunogenicity of the yeast recombinant p17/p24:Ty virus-like particles (p24-VLP) in healthy volunteers. Vaccine (1995) 0.95

Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccination. Immunol Lett (2001) 0.95

Lymphocyte proliferation and cytotoxic assays using flat-bed scintillation counting. J Immunol Methods (1987) 0.93

Lessons from IAVI-006, a phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers. Vaccine (2008) 0.93

NKG2C+ NK cells are enriched in AIDS patients with advanced-stage Kaposi's sarcoma. J Virol (2006) 0.93

Loss of the CD56hiCD16- NK cell subset and NK cell interferon-gamma production during antiretroviral therapy for HIV-1: partial recovery by human growth hormone. Clin Exp Immunol (2003) 0.92

The exon A (C77G) mutation is a common cause of abnormal CD45 splicing in humans. J Immunol (2001) 0.91

The effect of local injury upon the excitatory electrical response of nerve. J Physiol (1902) 0.89

A phase I trial in HIV negative healthy volunteers evaluating the effect of potent adjuvants on immunogenicity of a recombinant gp120W61D derived from dual tropic R5X4 HIV-1ACH320. Vaccine (2000) 0.89

Early initiation of chronic dialysis: role of incremental dialysis. Perit Dial Int (1997) 0.88

Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations. Ann Oncol (2003) 0.88

Amplified antigen-specific immune responses in HIV-1 infected individuals in a double blind DNA immunization and therapy interruption trial. Vaccine (2011) 0.87

Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes. Nature (1989) 0.86

Immune correlates of protection from HIV and AIDS - more answers but yet more questions. Immunol Today (1999) 0.85

A pilot study of the safety and efficacy of thymosin alpha 1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy. Clin Exp Immunol (2003) 0.83

The stability between two HIV-1 RNA measurements one year apart and the relationship with HIV subtype in rural Uganda. Int J STD AIDS (2001) 0.83

The role of cytotoxic T-cells in HIV infection. Dev Biol Stand (1998) 0.82

Induction of single and dual cytotoxic T-lymphocyte responses to viral proteins in mice using recombinant hybrid Ty-virus-like particles. Immunology (1996) 0.82

Dysregulated immunophenotypic attributes of plasmacytoid but not myeloid dendritic cells in HIV-1 infected individuals in the absence of highly active anti-retroviral therapy. Clin Exp Immunol (2012) 0.82

Recognition of influenza virus proteins by cytotoxic T lymphocytes. Philos Trans R Soc Lond B Biol Sci (1989) 0.81

Prospects for immune reconstitution in HIV-1 infection. Clin Exp Immunol (2002) 0.81

The measured creatinine generation rate in CAPD suggests only 78% of prescribed dialysis is delivered. Adv Perit Dial (1993) 0.79

Mycobacterial immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy is associated with deregulated specific T-cell responses: beneficial effect of IL-2 and GM-CSF immunotherapy. J Immune Based Ther Vaccines (2005) 0.79

Development of immunotherapeutic strategies for HIV-1. Expert Opin Biol Ther (2001) 0.79

Precise anticoagulation for routine hemodialysis. J Lab Clin Med (1978) 0.78

Treatment of primary HIV-1 infection with nonnucleoside reverse transcriptase inhibitor-based therapy is effective and well tolerated. HIV Med (2004) 0.78

HLA-A, -B, -C, -DRB1, DRB3, DRB4, DRB5 and DQB1 polymorphism detected by PCR-SSP in a semi-urban HIV-positive Ugandan population. Exp Clin Immunogenet (1999) 0.78

'Naïve' and 'memory' CD4+ T-cells and T-cell receptor (TCR) V beta repertoire dynamics are independent of the levels of viremia following HIV seroconversion. Immunol Lett (1999) 0.78

Role of the thymus in T lymphocyte reconstitution. Transplantation (2000) 0.77

Urea kinetics: a guide to nutritional management of renal failure. Am J Clin Nutr (1978) 0.77

Chronic hemodialysis with the hollow fiber artificial kidney (HFAK). Trans Am Soc Artif Intern Organs (1969) 0.77

Model-based inference of recombination hotspots in a highly variable oncogene [corrected]. J Mol Evol (2004) 0.77

HIV-1 RNA levels in an African population-based cohort and their relation to CD4 lymphocyte counts and World Health Organization clinical staging. J Acquir Immune Defic Syndr (1999) 0.77

Thymic activity in late-stage HIV-1 infected individuals receiving highly active antiretroviral therapy: potential effect of steroid therapy. HIV Med (2002) 0.77

Association between a defective CCR-5 gene and progression to disease in HIV infection. AIDS Res Hum Retroviruses (1998) 0.76

T-cell telomere length maintained in HIV-infected long-term survivors. HIV Med (2000) 0.76

Recognition of viral antigens at the cell surface. Cancer Surv (1995) 0.76

Molecular correlates in AIDS patients following antiretroviral therapy: diversified T-cell receptor repertoires and in vivo control of cytomegalovirus replication. HIV Med (2001) 0.76

Reversal of abnormalities of neutrophil adhesion molecule expression in HIV infection following protease inhibitor therapy. AIDS (1998) 0.75

Future vaccines for HIV. Lancet (1997) 0.75

Intensity of hemodialysis and response of erythropoietin. N Engl J Med (1996) 0.75

A positive correlation of PCRN to KT/V in cross-sectional studies is not proof of a causal relationship. Perit Dial Int (1995) 0.75

Reduction of HIV transmission in HIV-discordant couples wishing to conceive. AIDS (2001) 0.75

Urea kinetic modeling: a proven quantitative technique in dialysis therapy. Nephrol News Issues (1989) 0.75

Enhanced peritoneal dialysis delivery with PD-PLUS. Adv Perit Dial (1992) 0.75

Immune interventions. Br Med Bull (2001) 0.75

[Pseudotumor cerebri]. Nihon Rinsho (1977) 0.75

An Account of Certain Phenomena of Colour Vision with Intermittent Light. J Physiol (1897) 0.75

THE ELECTRIC FISH OF THE NILE. Science (1899) 0.75

Recombination does not occur in newly identified diverged oceanic picornaviruses. J Mol Evol (2004) 0.75

Effect of intradialytic parenteral nutrition on delivered Kt/V. Am J Kidney Dis (1999) 0.75

Kinetics and quality assurance: prescription therapy through kinetic modeling. ANNA J (1991) 0.75

An Inductor-Alternator for Physiological Experiments. J Physiol (1897) 0.75

A mathematical model comparing solute kinetics in low- and high-BMI hemodialysis patients. Int J Artif Organs (2007) 0.75

Clinical evaluation of a peritoneal dialysis kinetic modeling set. Adv Perit Dial (1996) 0.75

The use of heated citric acid for dialyzer reprocessing. J Am Soc Nephrol (1995) 0.75

Sorbent augmented dialysis systems. Contrib Nephrol (2002) 0.75

Comparative solute transport and therapeutic effectiveness of multiple point support and standard Kiil hemodialyzers. Trans Am Soc Artif Intern Organs (1972) 0.75

Detection and quantification of HIV-1 specific CD4 helper and CD8 cytotoxic cells: their role in HIV-1-infected individuals and vaccine recipients. HIV Med (2001) 0.75

Identification of a new HLA-A allele (A*2502) by PCR-SSP. Immunogenetics (1996) 0.75

Development and long term clinical evaluation of a thromboresistant hollow fiber kidney (HFK). Trans Am Soc Artif Intern Organs (1972) 0.75